Skip to main content

Table 2 Impact score factors

From: Towards a cardiac allocation score: a retrospective calculation for 73 patients from a German transplant center

  Overall T-status HU/U status p Valuea
Variables
Age, years     0.237
  > 60 27 14 (35.9%) 13 (24.5%)  
  ≤ 60 65 25 (64.1%) 40 (75.5%)  
Bilirubin, mg/dl     0.050
 0-0.99 53 28 (77.8%) 25 (49.0%)  
 1-1.99 27 6 (16.7%) 21 (41.2%)  
 2-3.99 6 2 (5.6%) 4 (7.8%)  
  ≥ 4 1 0 1 (2.0%)  
Creatinine Clearance, ml/min     0.752
  ≥ 50 75 30 (85.7%) 45 (88.2%)  
 30-49 11 5 (14.3%) 6 (11.8%)  
  < 30 0 0 0  
Dialysis between listing and transplant 5 1 (2.7%) 4 (7.5%) 0.645
Female sex 19 12 (30.8%) 7 (13.2%) 0.040
Diagnosis     0.036
 Ischemic 46 16 (41.0%) 30 (56.6%)  
 Idiopathic 34 20 (51.3%) 14 (26.4%)  
 Congenital 5 0 5 (9.4%)  
 Other 7 3 (7.7%) 4 (7.5%)  
Infection 13 1 (2.7%) 12 (22.6%) 0.026
IABP 11 1 (2.7%) 10 (18.9%) 0.024
Mechanical ventilation prior to Tx 2 0 2 (3.8%) 0.510
Circulatory support 8 0 8 (15.1%) 0.019
Ventricular assist deviced     <0.001
 No VAD 50 34 (87.2%) 16 (32.7%)  
 Early Generation PFb 23 3 (7.7%) 20 (40.8%)  
 New Generation CFc 3 0 3 (6.1%)  
 Heartmate II 12 2 (5.1%) 10 (20.4%)  
  1. Race is not listed because all patients were Caucasian
  2. IABP Intraaortic balloon pump, Tx Transplantation
  3. ap value based on X2 test or Fisher’s exact test
  4. bEarly Generation pulsatile flow includes Heartmate I, Thoratec (LVAD,RVAD,BVAD)), Novacor
  5. cNew Generation continuous flow includes Jarvik, Incor, Ventracor
  6. d4 Patients with total artificial heart were not included